USBC
Seattle
About USBC
USBC is a non-invasive diagnostic technology platform that uses radio waves to identify and measure molecules in the body. Its Bio-RFI platform uses electromagnetic energy and can be integrated into a variety of wearable, mobile, or bench-top form factors. The first application of its technology is a glucose monitor device, the UBAND. It will provide the user with real-time information on their blood glucose levels, assisting billions of people with diabetes and pre-diabetes to manage this medical condition. USBC is a public company whose shares trade under the stock symbol USBC. The company was incorporated in 2003 and is based in Seattle, Washington.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $52.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2024)
- Ticker: nysemkt:USBC
- Website: usbc.xyz
- Phone: +1 206-903-1351
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Wearables
Social Profiles
Canonical: https://fsome.com/organization/usbc-26441 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.